Knocking out salicylate biosynthesis genes in Mycobacterium smegmatis induces hypersensitivity to p-aminosalicylate (PAS)

FEMS Microbiology Letters

Volumn 311, Issue 2, 2010, Pages 193-199

  Nagachar, Nivedita ^a   Ratledge, Colin ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

Author keywords

mycobacteria; mycobactin; p aminosalicylate (PAS); salicylic acid

Indexed keywords

AMINOSALICYLIC ACID; DAPSONE; IRON; MYCOBACTIN; SALICYLIC ACID; SIDEROPHORE; SULFONAMIDE; TRIMETHOPRIM; UNCLASSIFIED DRUG;

ANTIBIOTIC BIOSYNTHESIS; ARTICLE; BACTERIAL GROWTH; BACTERIUM MUTANT; DRUG ACCUMULATION; DRUG EFFECT; DRUG HYPERSENSITIVITY; GENE INACTIVATION; IRON DEFICIENCY; MYCOBACTERIUM SMEGMATIS; NONHUMAN; PRIORITY JOURNAL; WILD TYPE;

AMINOSALICYLIC ACID; ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; GENE KNOCKOUT TECHNIQUES; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM SMEGMATIS; SALICYLATES;

CORYNEBACTERINEAE; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS;

EID: 77957304787     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2010.02091.x     Document Type: Article

References (28)

1. Adilakshmi T, Ayling PD Ratledge C (2000) Mutational analysis of a role for salicylic acid in iron metabolism of Mycobacterium smegmatis. J Bacteriol 182 : 264 271.
2. Boelaert JR, Vandecasteele SJ, Appelberg R Gordeuk VR (2007) The effect of the host's iron status on tuberculosis. J Infect Dis 195 : 1745 1753.
3. Brown KA Ratledge C (1975) The effect of p-aminosalicyclic acid on iron transport and assimilation in mycobacteria. Biochim Biophys Acta 385 : 207 220.
4. De Voss JJ, Rutter K, Schroeder BG, Su H, Zhu Y Barry CE III. (2000) The salicylate-derived mycobactin siderophores of Mycobacterium tuberculosis are essential for growth in macrophages. P Natl Acad Sci USA 97 : 1252 1257.
5. Kulkarni VM Seydel JK (1983) Inhibitory activity and mode of action of diaminodiphenylsulfone in cell-free folate-synthesizing systems prepared from Mycobacterium lufu and Mycobacterium leprae. A comparison. Chemotherapy 29 : 58 67.
6. Lehmann J (1946) p-Aminosalicylic acid in the treatment of tuberculosis. Lancet 1 : 15 16.
7. Luo M, Fadeev EA Groves JT (2005) Mycobactin-mediated iron acquisition within macrophages. Nat Chem Biol 1 : 149 153.
8. Mathys V, Wintjens R, Lefevre P et al 2009) Molecular genetics of para-aminosalicylic acid resistance in clinical isolates and spontaneous mutants of Mycobacterium tuberculosis. Antimicrob Agents Ch 53 : 2100 2109.
9. McDermid JM Prentice AM (2006) Iron and infection: effects of host iron status and the iron-regulatory genes haptoglobin and NRAMP1 (SLC11A1) on host-pathogen interactions in tuberculosis and HIV. Clin Sci (London) 110 : 503 524.
10. Morrison NE (1971) Sequential blockade of the mycobacterial de novo folate pathway. A review. Int J Leprosy 39 : 34 43.
11. Nagachar N Ratledge C (2010) Roles of trpE2, entC and entD in salicylic acid biosynthesis in Mycobacterium smegmatis. FEMS Microbiol Lett 308 : 159 165.
12. Patole J, Shingnapurkar D, Padhye S Ratledge C (2006) Schiff base conjugates of p-aminosalicylic acid as antimycobacterial agents. Bioorg Med Chem Lett 16 : 1514 1517.
13. Payne RJ, Bulloch EM, Toscano MM, Jones MA, Kerbarh O Abell C (2009) Synthesis and evaluation of 2,5-dihydrochorismate analogues as inhibitors of the chorismate-utilising enzymes. Org Biomol Chem 7 : 2421 2429.
14. Quadri LE, Sello J, Keating TA, Weinreb PH Walsh CT (1998) Identification of a Mycobacterium tuberculosis gene cluster encoding the biosynthetic enzymes for assembly of the virulence-conferring siderophore mycobactin. Chem Biol 5 : 631 645.
15. Ratledge C (1999) Iron metabolism. Mycobacteria: Molecular Biology and Virulence (Ratledge C Dale J, eds), pp. 260 286. Blackwell Science, Oxford, UK.
16. Ratledge C (2004) Iron, mycobacteria and tuberculosis. Tuberculosis 84 : 110 130.
17. Ratledge C Brown KA (1972) Inhibition of mycobactin formation in Mycobacterium smegmatis by p-aminosalicylate. A new proposal for the mode of action of p-aminosalicylate. Am Rev Respir Dis 106 : 774 776.
18. Ratledge C Dover LG (2000) Iron metabolism in pathogenic bacteria. Annu Rev Microbiol 54 : 881 941.
19. Ratledge C Ewing M (1996) The occurrence of carboxymycobactin, the siderophore of pathogenic mycobacteria, as a second extracellular siderophore in Mycobacterium smegmatis. Microbiology 142 : 2207 2212.
20. Ratledge C Hall MJ (1971) Influence of metal ions on the formation of mycobactin and salicylic acid in Mycobacterium smegmatis grown in static culture. J Bacteriol 108 : 314 319.
21. Ratledge C Hall MJ (1972) Isolation and properties of auxotrophic mutants of Mycobacterium smegmatis requiring either salicylic acid or mycobactin. J Gen Microbiol 72 : 143 150.
22. Rees RJ (1967) Drug resistance of Mycobacterium leprae, particularly to DDS. Int J Leprosy 35 : 625 638.
23. Rengarajan J, Sassetti CM, Naroditskaya V, Sloutsky A, Bloom BR Rubin EJ (2004) The folate pathway is a target for resistance to the drug para-aminosalicylic acid (PAS) in mycobacteria. Mol Microbiol 53 : 275 282.
24. Schaible UE Kaufmann SH (2004) Iron and microbial infection. Nat Rev Microbiol 2 : 946 953.
25. Snow GA (1965) Isolation and structure of mycobactin T, a growth factor from Mycobacterium tuberculosis. Biochem J 97 : 166 175.
26. Somu RV, Boshoff H, Qiao C, Bennett EM, Barry CE III. Aldrich CC (2006) Rationally designed nucleoside antibiotics that inhibit siderophore biosynthesis of Mycobacterium tuberculosis. J Med Chem 49 : 31 34.
27. Winder FG (1964) The antimicrobial action of streptomycin, isoniazid and PAS. Chemotherapy of Tuberculosis (Barry VC, ed.), pp. 111 149. Butterworth, London.
28. Winder FG (1982) Mode of action of the antimycobacterial agents and associated aspects of the molecular biology of the mycobacteria. The Biology of the Mycobacteria, Vol. 1 (Ratledge C Stanford J, eds), pp. 353 438. Academic Press, London.